| 21.11.2008 |
|
HBM BioVentures holds over 5% of its own shares |
| 12.11.2008 |
|
Sale of private portfolio company Panomics |
| 27.10.2008 |
|
HBM BioVentures quarterly report as at 30 September 2008 - stable net asset value (NAV) |
| 9.10.2008 |
|
HBM BioVentures holds over 3% of its own shares |
| 30.9.2008 |
|
Disclosure of shareholdings in accordance with Articles 9 and 17 of the Federal Act of Stock Exchanges and Securities Trading - SFBC |
| 26.9.2008 |
|
Takeover of public portfolio company CryoCath Technologies |
24.9.2008
|
|
Share buyback - listing advertisement English
Share buyback - listing advertisement French
Share buyback - listing advertisement German |
22.9.2008
|
|
HBM BioVentures launches share buyback programme and resolves to make par value repayments |
| 30.7.2008 |
|
HBM BioVentures quarterly report as at 30 June 2008 - private portfolio boosts value |
| 22.7.2008 |
|
Significant cooperation agreement for portfolio company PTC Therapeutics
|
30.6.2008
|
|
Annual General Meeting of HBM BioVentures Ltd - all Board of Directors proposals approved
|
30.6.2008
|
|
Capital management measures to boost share appeal |
5.6.2008
|
|
Successful private portfolio positions reduce negative impact of difficult equity market climate in 2007/2008 financial year |
20.5.2008
|
|
New financing for the porfolio company PharmaSwiss - positive impact on HBM BioVentures' net asset value (NAV) of CHF 2.90 per share
|
2.5.2008
|
|
HBM BioVentures realises remaining gains on USD currency hedge positions
|
11.3.2008
|
|
HBM BioVentures realises gains on USD currency hedge positions
|
6.2.2008
|
|
The first day of trading in HBM BioVentures shares on the SWX Swiss Exchange is 14 February 2008
|
28.1.2008
|
|
HBM BioVentures announces further information of its planned IPO on the SWX Swiss Exchange |
| 14.1.2008 |
|
HBM BioVentures to apply for listing on the SWX Swiss Exchange |
